|
1
|
Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.
|
J Exp Med
|
2003
|
3.89
|
|
2
|
Central nervous system injury-induced immune deficiency syndrome.
|
Nat Rev Neurosci
|
2005
|
3.45
|
|
3
|
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.
|
Lancet Neurol
|
2009
|
2.98
|
|
4
|
Stroke-induced immunodepression: experimental evidence and clinical relevance.
|
Stroke
|
2007
|
2.76
|
|
5
|
Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial.
|
PLoS One
|
2008
|
2.39
|
|
6
|
The immunology of acute stroke.
|
Nat Rev Neurol
|
2012
|
2.06
|
|
7
|
Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.
|
J Neurosci
|
2002
|
2.05
|
|
8
|
Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia.
|
J Neuroimmunol
|
2007
|
1.85
|
|
9
|
Controlled growth of tetrapod-branched inorganic nanocrystals.
|
Nat Mater
|
2003
|
1.76
|
|
10
|
Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin.
|
Stroke
|
2003
|
1.65
|
|
11
|
Pathophysiology of stroke: lessons from animal models.
|
Metab Brain Dis
|
2004
|
1.61
|
|
12
|
Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro.
|
J Cereb Blood Flow Metab
|
2002
|
1.44
|
|
13
|
Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans.
|
Cerebrovasc Dis
|
2007
|
1.42
|
|
14
|
Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.
|
Mol Neurobiol
|
2009
|
1.42
|
|
15
|
Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia.
|
Stroke
|
2006
|
1.39
|
|
16
|
Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?
|
Neuropharmacology
|
2008
|
1.31
|
|
17
|
Sugar for the brain: the role of glucose in physiological and pathological brain function.
|
Trends Neurosci
|
2013
|
1.25
|
|
18
|
Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic stroke.
|
Stroke
|
2012
|
1.22
|
|
19
|
Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia.
|
J Neurosci
|
2002
|
1.22
|
|
20
|
Increased postischemic brain injury in mice deficient in uracil-DNA glycosylase.
|
J Clin Invest
|
2004
|
1.22
|
|
21
|
Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury.
|
Exp Neurol
|
2007
|
1.21
|
|
22
|
Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke.
|
Stroke
|
2003
|
1.21
|
|
23
|
Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
|
Ann Rheum Dis
|
2012
|
1.18
|
|
24
|
Thoracoscopic thymectomy with the da Vinci robotic system for myasthenia gravis.
|
Ann N Y Acad Sci
|
2008
|
1.17
|
|
25
|
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE.
|
J Mol Med (Berl)
|
2008
|
1.14
|
|
26
|
Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1/Cip1) as a novel mechanism of neuroprotection by glucocorticoids.
|
J Neurosci
|
2007
|
1.12
|
|
27
|
Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO.
|
J Cereb Blood Flow Metab
|
2012
|
1.11
|
|
28
|
Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state.
|
Proc Natl Acad Sci U S A
|
2012
|
1.07
|
|
29
|
Decision-making in the diagnosis and treatment of stroke-associated pneumonia.
|
J Neurol Neurosurg Psychiatry
|
2012
|
1.05
|
|
30
|
Suppressing immunosuppression after stroke.
|
N Engl J Med
|
2011
|
1.05
|
|
31
|
Effects of the PDE5-inhibitor vardenafil in a mouse stroke model.
|
Brain Res
|
2009
|
1.03
|
|
32
|
Association between socioeconomic status and functional impairment 3 months after ischemic stroke: the Berlin Stroke Register.
|
Stroke
|
2012
|
1.02
|
|
33
|
Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection.
|
Cerebrovasc Dis
|
2011
|
1.01
|
|
34
|
Immunodepression after aneurysmal subarachnoid hemorrhage.
|
Stroke
|
2010
|
0.96
|
|
35
|
Gait analysis as a method for assessing neurological outcome in a mouse model of stroke.
|
J Neurosci Methods
|
2012
|
0.94
|
|
36
|
Epigenetic mechanisms in cerebral ischemia.
|
J Cereb Blood Flow Metab
|
2013
|
0.93
|
|
37
|
Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.
|
Neurotoxicology
|
2007
|
0.92
|
|
38
|
Do stroke models model stroke?
|
Dis Model Mech
|
2012
|
0.91
|
|
39
|
Doxorubicin induces biphasic neurotoxicity to rat cortical neurons.
|
Neurotoxicology
|
2007
|
0.90
|
|
40
|
Protection from brain damage and bacterial infection in murine stroke by the novel caspase-inhibitor Q-VD-OPH.
|
Exp Neurol
|
2007
|
0.89
|
|
41
|
Seroprevalence of anti-N-methyl-D-aspartate receptor antibodies in women with ovarian teratoma.
|
J Neurol
|
2013
|
0.88
|
|
42
|
Serum insulin-like growth factor I and ischemic brain injury.
|
Brain Res
|
2007
|
0.87
|
|
43
|
Mouse strains differ in their susceptibility to poststroke infections.
|
Neuroimmunomodulation
|
2006
|
0.86
|
|
44
|
Enlarging the nosological spectrum of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS).
|
Brain Pathol
|
2014
|
0.86
|
|
45
|
Progressive external ophthalmoplegia as initial manifestation of sporadic late-onset nemaline myopathy.
|
J Neurol
|
2010
|
0.86
|
|
46
|
Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS).
|
J Cachexia Sarcopenia Muscle
|
2013
|
0.86
|
|
47
|
Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells.
|
Toxicol Lett
|
2012
|
0.86
|
|
48
|
Folate deficiency increases postischemic brain injury.
|
Stroke
|
2004
|
0.85
|
|
49
|
Differential affection of intestinal immune cell populations after cerebral ischemia in mice.
|
Neuroimmunomodulation
|
2009
|
0.85
|
|
50
|
Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: a bed to bench approach.
|
J Cereb Blood Flow Metab
|
2013
|
0.84
|
|
51
|
Evidence of intrathecal immunoglobulin synthesis in stroke: a cohort study.
|
Arch Neurol
|
2012
|
0.82
|
|
52
|
Physical fitness training in Subacute Stroke (PHYS-STROKE)--study protocol for a randomised controlled trial.
|
Trials
|
2014
|
0.82
|
|
53
|
Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia.
|
J Pharmacol Exp Ther
|
2005
|
0.82
|
|
54
|
The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons.
|
Neurotoxicology
|
2012
|
0.81
|
|
55
|
Alpha-MSH promotes spontaneous post-ischemic pneumonia in mice via melanocortin-receptor-1.
|
Exp Neurol
|
2008
|
0.80
|
|
56
|
Miniaturized bronchoscopy enables unilateral investigation, application, and sampling in mice.
|
Am J Respir Cell Mol Biol
|
2014
|
0.80
|
|
57
|
Neuronal nitric oxide synthase is a key factor in doxorubicin-induced toxicity to rat-isolated cortical neurons.
|
Neurotox Res
|
2009
|
0.80
|
|
58
|
STRoke Adverse outcome is associated WIth NoSocomial Infections (STRAWINSKI): procalcitonin ultrasensitive-guided antibacterial therapy in severe ischaemic stroke patients - rationale and protocol for a randomized controlled trial.
|
Int J Stroke
|
2012
|
0.80
|
|
59
|
Influence of acute complications on outcome 3 months after ischemic stroke.
|
PLoS One
|
2013
|
0.79
|
|
60
|
Inducible nitric oxide synthase does not mediate brain damage after transient focal cerebral ischemia in mice.
|
J Cereb Blood Flow Metab
|
2007
|
0.79
|
|
61
|
Impact of infections on long-term outcome after severe middle cerebral artery infarction.
|
J Neurol Sci
|
2012
|
0.79
|
|
62
|
Models of infection before and after stroke: investigating new targets.
|
Infect Disord Drug Targets
|
2010
|
0.79
|
|
63
|
A functional role of the cyclin-dependent kinase inhibitor 1 (p21(WAF1/CIP1)) for neuronal preconditioning.
|
J Cereb Blood Flow Metab
|
2013
|
0.78
|
|
64
|
Disturbed B cell subpopulations and increased plasma cells in myasthenia gravis patients.
|
J Neuroimmunol
|
2013
|
0.77
|
|
65
|
Biomarkers and perfusion--training-induced changes after stroke (BAPTISe): protocol of an observational study accompanying a randomized controlled trial.
|
BMC Neurol
|
2013
|
0.77
|
|
66
|
Impact of selection criteria on recruitment in an interventional stroke trial.
|
Cerebrovasc Dis
|
2013
|
0.77
|
|
67
|
Tourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride.
|
Mov Disord
|
2004
|
0.76
|
|
68
|
5,7-Dihydroxitryptamine toxicity to serotonergic neurons in serum free raphe cultures.
|
Eur J Pharmacol
|
2008
|
0.76
|
|
69
|
Effect of 3,4-methylenedioxyamphetamine on dendritic spine dynamics in rat neocortical neurons--involvement of heat shock protein 27.
|
Brain Res
|
2010
|
0.75
|
|
70
|
Isolated abducens nerve paresis associated with high titer of anti-asialo-GM1 following Campylobacter jejuni enteritis.
|
J Neurol
|
2004
|
0.75
|
|
71
|
Energy and charge transfer in blends of dendronized perylenes with polyfluorene.
|
J Chem Phys
|
2008
|
0.75
|